Home
About Us
Research
Product Development
Shareholder Information
News
Commencing Human Clinical Trials of Cuprindo™
...clinical trials of Cuprindo™ to determine its safety...
Clinical collaboration agreement signed, 4 Jun 07
....for up to three GI indications....
Sucessful Settlement of Dispute
...MTY successfully settled its dispute with The University of Sydney...
Latest Shareholder Update, 1 Feb 08
...Welcome to this second edition of MTY News...
Feature Article - Australian Investor Magazine
...making dramatic moves with new CEO...
Positive Clinical Interim Results
...completed its ‘first-in-human’ clinical trial...
Medical Therapies Ltd
(MTY):
Join Our Mailing List
We invite you to join our mailing list to receive our announcements electronically. To join, simply complete the form below:
Salutation
Mr
Mrs
Miss
Ms
Dr
Prof
First Name
Last Name
Email Address
Reason for Interest
Investment
Clinical Trials
Scientific / Educational
Media
Other
If Other Please Specify
© Medical Therapies
Privacy
|
Contact Us
Medical Therapies Ltd ABN 69 111 304 119 T: +61 2 9299 0311 E:
info@medicaltherapies.com.au